Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma

Talimogene laherparepvec (T-VEC) has demonstrated efficacy for unresectable melanoma. We explored response patterns from a phase 2 study evaluating patients with unresectable stage IIIB–IVM1c malignant melanoma who received T-VEC plus ipilimumab or ipilimumab alone. Patients with objective response...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Chesney, Jason, Puzanov, Igor, Collichio, Frances, Milhem, Mohammed M., Hauschild, Axel, Chen, Lisa, Sharma, Anjali, Garbe, Claus, Singh, Parminder, Mehnert, Janice M.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Brief Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738060/
https://ncbi.nlm.nih.gov/pubmed/31353364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0530-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados